Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Drug Resistance

Free Subscription Articles published in J Infect Chemother Retrieve available abstracts of 53 articles: HTML format

Single Articles

July 2025
1. DANZUKA Y, Nakamura K, Matsumoto S, Etoh Y, et al
   Successive SARS-CoV-2 mutations in a highly susceptible host: A case report of persistent viremia and fatality.
   J Infect Chemother. 2025;31:102737.
   PubMed     Abstract available
   
   
   
2. KANEKO A, Iwabuchi H, Sato J, Matsumoto T, et al
   Antimicrobial susceptibility surveillance of bacterial isolates recovered in Japan from odontogenic infections in 2018.
   J Infect Chemother. 2025;31:102731.
   PubMed     Abstract available
   
   
   
3. LOTFIAN Z, Nave HH, Khalili R, Saffari F, et al
   Contribution of efflux activity in resistance to antibiotics in Escherichia coli clinical isolates.
   J Infect Chemother. 2025;31:102725.
   PubMed     Abstract available
   
   
   June 2025
4. ISHIKAWA K, Shibutani K, Mikami Y, Harada S, et al
   Successful treatment of an intra-abdominal abscess caused by KPC-2-producing hypervirulent Klebsiella pneumoniae sequence type 11 with imipenem/cilastatin/relebactam in a Japanese patient.
   J Infect Chemother. 2025;31:102717.
   PubMed     Abstract available
   
   
   
5. SASAKI Y, Horiuchi H, Umehara A, Yano M, et al
   Longitudinal impact of a pharmacist-led stepwise antimicrobial stewardship program on intravenous antimicrobial use at a small resource-limited Japanese hospital.
   J Infect Chemother. 2025;31:102697.
   PubMed     Abstract available
   
   
   May 2025
6. YAMAMOTO K, Hayashi H, Mizuta K, Fukushima R, et al
   Impact of the COVID-19 pandemic on the regional epidemiology of methicillin-resistant Staphylococcus aureus in the Kumamoto region.
   J Infect Chemother. 2025 May 29:102743. doi: 10.1016/j.jiac.2025.102743.
   PubMed     Abstract available
   
   
   
7. IWASAKI T, Koide K, Kido T, Nakagawa S, et al
   Fatal Case of Macrolide-Resistant Bordetella pertussis Infection, Japan, 2024.
   J Infect Chemother. 2025 May 8:102727. doi: 10.1016/j.jiac.2025.102727.
   PubMed     Abstract available
   
   
   April 2025
8. FURUYA K, Sugiyama K, Suzuki K, Yamamoto M, et al
   Active surveillance of vancomycin-resistant Enterococcus faecium after its outbreak at patient admission.
   J Infect Chemother. 2025;31:102718.
   PubMed     Abstract available
   
   
   
9. UMEMURA K, Katada Y, Katsube Y, Hira D, et al
   Optimizing cytomegalovirus treatment through therapeutic drug monitoring in a ganciclovir-unresponsive lung transplant recipient.
   J Infect Chemother. 2025;31:102686.
   PubMed     Abstract available
   
   
   
10. THANH HOANG HT, Yamamoto M, Calvopina M, Bastidas-Caldes C, et al
    Ban of colistin livestock feed supplementation decreased the prevalence of colistin-resistant Escherichia coli in Ecuador.
    J Infect Chemother. 2025;31:102682.
    PubMed     Abstract available
    
    
    
11. KANESAKA I, Manoharan-Basil SS, De Block T, Kenyon C, et al
    Antimicrobial susceptibility of commensal Neisseria species in the Japanese population.
    J Infect Chemother. 2025;31:102670.
    PubMed     Abstract available
    
    
    
12. ZHU X, Ye T, Sun Y, Wang S, et al
    Transmission of a plasmid harboring NDM-1 gene between Salmonella Typhimurium and Escherichia coli strains in an infant.
    J Infect Chemother. 2025;31:102655.
    PubMed     Abstract available
    
    
    
13. SEMERCI Z, Akilli FM, Ilki A
    Evaluation of fosfomycin susceptibility testing methods: A focus on multidrug-resistant Klebsiella pneumoniae using ECOFF values.
    J Infect Chemother. 2025;31:102643.
    PubMed     Abstract available
    
    
    
14. SHIMADA T, Watanabe A, Akita K, Bando K, et al
    First reported case of disseminated Cunninghamella phaeospora infection with multidrug resistance in acute myeloid leukemia.
    J Infect Chemother. 2025;31:102646.
    PubMed     Abstract available
    
    
    
15. HASSAN BAR, Mohammed AH
    Development and validation of a knowledge questionnaire regarding the relationship between bacterial resistance and cancer among oncologists.
    J Infect Chemother. 2025;31:102638.
    PubMed     Abstract available
    
    
    
16. MARUYAMA K, Sekiya K, Yanagida N, Yasuda S, et al
    Seasonal variation in intravenous broad-spectrum antimicrobial use in Japan from 2018 to 2023.
    J Infect Chemother. 2025;31:102636.
    PubMed     Abstract available
    
    
    
17. MUHAMAD NDA, Kanie N, Otsubo Y, Suzuki K, et al
    Letermovir-inclusive combination therapy for a refractory and resistant infection by cytomegalovirus with UL54 mutation following a hematopoietic stem cell transplant for MHC class II deficiency.
    J Infect Chemother. 2025;31:102627.
    PubMed     Abstract available
    
    
    March 2025
18. TAKAHASHI H, Ohama Y, Horiba K, Fukusumi M, et al
    Emergence of high-level penicillin-resistant Neisseria meningitidis harboring ROB-1-type beta-lactamase gene in Japan.
    J Infect Chemother. 2025 Mar 11:102679. doi: 10.1016/j.jiac.2025.102679.
    PubMed     Abstract available
    
    
    
19. FERJANI S, Hamzaoui Z, Kanzari L, Fakhfekh A, et al
    Emergence of a methicillin-resistant Staphylococcus aureus strains with an unusual susceptibility antibiotic pattern in Tunisia.
    J Infect Chemother. 2025;31:102677.
    PubMed     Abstract available
    
    
    February 2025
20. FUKUSHIMA S, Hagiya H, Gotoh K, Tsuji S, et al
    Clinical and microbiological characteristics of high-level daptomycin-resistant Corynebacterium species: A systematic scoping review.
    J Infect Chemother. 2025;31:102575.
    PubMed     Abstract available
    
    
    
21. TSUYAMA N, Okawa N, Muranaka E, Mito H, et al
    Two cases with extensively drug-resistant Salmonella Typhi infection returning from Pakistan.
    J Infect Chemother. 2025;31:102568.
    PubMed     Abstract available
    
    
    
22. HAMADA Y, Yagi Y
    Therapeutic drug monitoring of azole antifungal agents.
    J Infect Chemother. 2025;31:102535.
    PubMed     Abstract available
    
    
    January 2025
23. LACINEL GURLEVIK S, Oygar PD, Koseoglu B, Hazirolan G, et al
    Is the high dose extended infusion of meropenem useful in the treatment of highly resistant gram-negative bacteria in children?
    J Infect Chemother. 2025;31:102498.
    PubMed     Abstract available
    
    
    December 2024
24. CHLOE CHUI SL, Lai SW, Huang PY, Cherrie Pang CC, et al
    Knowledge, perception, and behaviours related to antibiotic use and antimicrobial resistance in community-dwelling individuals in Hong Kong.
    J Infect Chemother. 2024 Dec 11:S1341-321X(24)00330.
    PubMed     Abstract available
    
    
    November 2024
25. BROOK I
    Overview of anaerobic infections in children and their treatment.
    J Infect Chemother. 2024;30:1104-1113.
    PubMed     Abstract available
    
    
    October 2024
26. KOMEDA T, Hishinuma T, Kirikae T, Tada T, et al
    Escherichia coli with increased aminoglycoside resistance due to an amino acid substitution at position 85 of HemC.
    J Infect Chemother. 2024 Oct 5:S1341-321X(24)00277.
    PubMed     Abstract available
    
    
    
27. HEMEDA MS, Elsayed HA, Mohamad AME, Ibrahim MM, et al
    Investigation of metronidazole resistance-associated mutations and virulence genotypes in helicobacter pylori isolates from the Egyptian population: A cross-sectional study.
    J Infect Chemother. 2024 Oct 2:S1341-321X(24)00274.
    PubMed     Abstract available
    
    
    
28. MORIOKA S, Tsuzuki S, Gu Y, Fujitomo Y, et al
    Factors associated with the change of antimicrobial prescription before and after the national action plan on antimicrobial resistance: Additional analysis of a nationwide survey conducted by the Japanese Society of Chemotherapy and the Japanese Assoc
    J Infect Chemother. 2024 Oct 2:S1341-321X(24)00273.
    PubMed     Abstract available
    
    
    
29. YOO IY, Ha SI, Kim SW, Kim JK, et al
    Carbapenem non-susceptibility overcalling by BD phoenix NMIC-500 panel.
    J Infect Chemother. 2024;30:1076-1080.
    PubMed     Abstract available
    
    
    
30. ALMANGOUR TA, Ghonem L, Alassiri D, Aljurbua A, et al
    Novel beta-lactam-beta-lactamase inhibitors as monotherapy versus combination for the treatment of drug-resistant Pseudomonas aeruginosa infections: A multicenter cohort study.
    J Infect Chemother. 2024;30:1008-1014.
    PubMed     Abstract available
    
    
    
31. LEE M, Lee CM, Byun JM, Shin DY, et al
    Risk factors for resistant gram-positive bacteremia in febrile neutropenic patients with cancer.
    J Infect Chemother. 2024;30:995-1000.
    PubMed     Abstract available
    
    
    September 2024
32. NAJARI E, Zamani S, Sheikh Arabi M, Ardebili A, et al
    Antimicrobial photodynamic effect of the photosensitizer riboflavin, alone and in combination with colistin, against pandrug-resistant Pseudomonas aeruginosa clinical isolates.
    J Infect Chemother. 2024;30:892-898.
    PubMed     Abstract available
    
    
    
33. HARADA K, Miyamoto T, Sugiyama M, Asai T, et al
    First report of a bla(NDM-5)-carrying Escherichia coli sequence type 12 isolated from a dog with pyometra in Japan.
    J Infect Chemother. 2024;30:938-941.
    PubMed     Abstract available
    
    
    August 2024
34. MATSUMOTO M, Hamasuna R, Wada K, Sadahira T, et al
    Fluoroquinolone resistance and clinical characteristics of acute bacterial prostatitis in Japan: A multicenter study by the Japanese research group for urinary tract infection.
    J Infect Chemother. 2024 Aug 14:S1341-321X(24)00221.
    PubMed     Abstract available
    
    
    
35. UKAI T, Ohkado A, Okumura M, Yoshiyama T, et al
    Two Cases of Iatrogenic Levofloxacin-Resistant Pre-XDR Tuberculosis in Japan.
    J Infect Chemother. 2024 Aug 6:S1341-321X(24)00212.
    PubMed     Abstract available
    
    
    
36. ITO A, Nanjo Y, Kajiwara C, Shiozawa A, et al
    Intrinsic clarithromycin heteroresistance in Mycobacterium avium.
    J Infect Chemother. 2024;30:752-756.
    PubMed     Abstract available
    
    
    July 2024
37. MITSUMOTO-KASEIDA F, Murata M, Ota K, Kaku N, et al
    Comparison of the effectiveness of core genome multilocus sequence typing and polymerase chain reaction-based open reading frame typing in tracing nosocomial methicillin-resistant Staphylococcus aureus transmission.
    J Infect Chemother. 2024 Jul 4:S1341-321X(24)00179.
    PubMed     Abstract available
    
    
    June 2024
38. ALHARTHI KF, Baotob SM, Bankhar AM, Alsehli AA, et al
    Characteristics and outcomes of urinary tract infections caused by Enterococci: A multicenter retrospective study from two tertiary hospitals in Saudi Arabia.
    J Infect Chemother. 2024 Jun 26:S1341-321X(24)00174.
    PubMed     Abstract available
    
    
    
39. MITSUTAKE K, Shinya N, Seki M, Ohara T, et al
    Clinical characteristics and analysis of prognostic factors in methicillin-resistant Staphylococcus aureus endocarditis: A retrospective multicenter study in Japan.
    J Infect Chemother. 2024 Jun 12:S1341-321X(24)00157.
    PubMed     Abstract available
    
    
    
40. SAXENA S, Aggarwal P, Mitra S, Singh S, et al
    In Vitro Assessment of Newer Colistin-Sparing Antimicrobial Agents for Clinical Isolates of Carbapenem-Resistant Organisms.
    J Infect Chemother. 2024 Jun 3:S1341-321X(24)00149.
    PubMed     Abstract available
    
    
    
41. SHARMA M, Dwivedi P, Joshi V, Singh P, et al
    Novel mutations found in Mycobacterium leprae DNA repair gene nth from central India.
    J Infect Chemother. 2024;30:531-535.
    PubMed     Abstract available
    
    
    May 2024
42. MASAYUKI M, Sunaga T, Sato MT, Hasegawa T, et al
    Efficacy of carbapenems and alternative antimicrobials for treating complicated urinary tract infections caused by caused by third-generation cephalosporin-resistant gram-negative bacteria: A systematic review and meta-analysis of randomised controlle
    J Infect Chemother. 2024 May 3:S1341-321X(24)00127.
    PubMed     Abstract available
    
    
    April 2024
43. KOBAYASHI K, Takahashi S, Yasuda M, Miyazaki J, et al
    Fourth national Japanese antimicrobial susceptibility pattern surveillance program: Bacterial isolates from patients with complicated urinary tract infections.
    J Infect Chemother. 2024 Apr 6:S1341-321X(24)00108.
    PubMed     Abstract available
    
    
    
44. MIURA-AJIMA N, Suwanthada P, Kongsoi S, Kim H, et al
    Effect of WQ-3334 on Campylobacter jejuni carrying a DNA gyrase with dominant amino acid substitutions conferring quinolone resistance.
    J Infect Chemother. 2024 Apr 3:S1341-321X(24)00110.
    PubMed     Abstract available
    
    
    March 2024
45. OGIHARA S, Yamaguchi T, Sato T, Aoki K, et al
    Assessing the discriminability of PCR-based open reading frame typing versus single-nucleotide polymorphism analysis via draft whole-genome sequencing of methicillin-resistant Staphylococcus aureus in nosocomial transmission analysis.
    J Infect Chemother. 2024 Mar 2:S1341-321X(24)00056.
    PubMed     Abstract available
    
    
    
46. LI Q, Tian P, Xu C, Peng Z, et al
    Increased expression of Mycobacterium tuberculosis Rv3737 gene associated with low-level amikacin resistance.
    J Infect Chemother. 2024;30:208-212.
    PubMed     Abstract available
    
    
    
47. MITSUTAKE K, Shinya N, Seki M, Ohara T, et al
    Antimicrobial therapy and outcome of methicillin-resistant Staphylococcus aureus endocarditis: A retrospective multicenter study in Japan.
    J Infect Chemother. 2024 Mar 1:S1341-321X(24)00068.
    PubMed     Abstract available
    
    
    January 2024
48. VIECELI T, Henrique LR, Rech TH, Zavascki AP, et al
    Colistin versus polymyxin B for the treatment of carbapenem-resistant Klebsiella pneumoniae bloodstream infections.
    J Infect Chemother. 2024 Jan 18:S1341-321X(24)00022.
    PubMed     Abstract available
    
    
    
49. ZHEN S, Lin Q, Chen Z, Shen Y, et al
    Ceftazidime-avibactam in the treatment of bacteremia due to carbapenem-resistant gram-negative bacteria in hematological patients: Experience in a single center.
    J Infect Chemother. 2024 Jan 10:S1341-321X(24)00011.
    PubMed     Abstract available
    
    
    
50. YOKOTA K, Kawakami K
    Efficacy and side-effect profile of tedizolid in the treatment of streptococcal toxic shock syndrome due to clindamycin-resistant Streptococcus pyogenes: A case report.
    J Infect Chemother. 2024 Jan 6:S1341-321X(24)00004.
    PubMed     Abstract available
    
    
    December 2023
51. EDA H, Arakawa Y, Yoshida T, Ogasawara F, et al
    Unilateral lymphadenitis caused by community-associated methicillin-resistant Staphylococcus aureus ST834 strain.
    J Infect Chemother. 2023 Dec 12:S1341-321X(23)00309.
    PubMed     Abstract available
    
    
    November 2023
52. OMORI K, Kitagawa H, Takada M, Maeda R, et al
    Fosfomycin as salvage therapy for persistent methicillin-resistant Staphylococcus aureus bacteremia: A case series and review of the literature.
    J Infect Chemother. 2023 Nov 3:S1341-321X(23)00269.
    PubMed     Abstract available
    
    
    October 2023
53. JUNG J, Kim YK, Chang E, Bae S, et al
    The origin of sequence type 72 community-associated methicillin-resistant Staphylococcus aureus (MRSA) and fusidic acid (FA) resistant sequence type 5 MRSA: Analysis of FA resistance and spa type in a single center in South Korea.
    J Infect Chemother. 2023 Oct 27:S1341-321X(23)00265.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.